pubmed· e01.org

PubMed · PMID 11778158

[Current status of cell-based therapies in liver diseases].

PMID 11778158Journal Zeitschrift fur GastroenterologieYear 2001Authors 3DOI 10.1055/s-2001-18540

  • Source PubMed
  • Journal Zeitschrift fur Gastroenterologie
  • Year 2001
  • Authors J Petersen; M Ott; F von Weizsäcker
  • Licence NLM/PubMed terms

Abstract

Major strides have been made during the past 10 years in the fields of liver cell transplantation and liver-directed gene therapy. Pre-clinical studies in animals have shown that primary hepatocytes transplanted into the liver as well as intravenously transfused bone marrow stem cells can generate new liver tissue. Such cell transplantation studies have contributed to our understanding of organogenesis and hepatocyte biology.

Furthermore, transplantation of xenogenic hepatocytes has led to the development of new small animal models for studying viral hepatitis. In the clinical setting, liver cell transplantation offers a wide range of potential therapeutic applications, especially in metabolic diseases. In particular, the case of a patient with Crigler-Najjar Syndrome Type I clearly demonstrated the long-term viability of transplanted hepatocytes with stable metabolic function.

Further studies are warranted to assess the full potential of cell- based therapies and their clinical application.

Record details

PMID11778158
PMCIDnot held
DOI10.1055/s-2001-18540
JournalZeitschrift fur Gastroenterologie
Year2001
AuthorsJ Petersen; M Ott; F von Weizsäcker
Licencenot stated
MeSHAnimals; Bone Marrow Transplantation; Cell Survival; Cell Transplantation; Crigler-Najjar Syndrome; Humans; Liver; Liver Diseases; Treatment Outcome

Source record

Open the PubMed record. This page holds the abstract and citation fields for this PMID; no PMC full text is held for it.

Source
PubMed / NLM
PMID
11778158
Rendered
2026-11-22
Completeness
abstract and citation fields